104 related articles for article (PubMed ID: 2337737)
1. Chimerism studies using in situ hybridization for the Y chromosome after T cell-depleted bone marrow transplantation.
Przepiorka D; Gonzales-Chambers R; Winkelstein A; Rosenfeld C; Shadduck RK
Bone Marrow Transplant; 1990 Apr; 5(4):253-7. PubMed ID: 2337737
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
3. Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.
Lamb LS; Szafer F; Henslee-Downey PJ; Walker M; King S; Godder K; Pati AR; Best R; Steinman L; Geier SS
Exp Hematol; 1995 Dec; 23(14):1595-600. PubMed ID: 8542952
[TBL] [Abstract][Full Text] [Related]
4. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Kedar E; Or R; Naparstek E; Zeira E; Slavin S
Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.
Small TN; Avigan D; Dupont B; Smith K; Black P; Heller G; Polyak T; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Jun; 3(2):65-75. PubMed ID: 9267666
[TBL] [Abstract][Full Text] [Related]
6. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
7. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
[TBL] [Abstract][Full Text] [Related]
8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
9. Acute rejection of marrow grafts in patients transplanted from a partially mismatched related donor: clinical and immunologic characteristics.
Lamb LS; Gee AP; Parrish RS; Lee C; Walker M; Geier S; Harris G; Pati A; Godder K; Henslee-Downey PJ
Bone Marrow Transplant; 1996 Jun; 17(6):1021-7. PubMed ID: 8807109
[TBL] [Abstract][Full Text] [Related]
10. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease.
Gyger M; Baron C; Forest L; Lussier P; Lagacé F; Bissonnette I; Bélanger R; Bonny Y; Busque L; Roy DC; Perreault C
Exp Hematol; 1998 May; 26(5):426-34. PubMed ID: 9590660
[TBL] [Abstract][Full Text] [Related]
12. Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens.
Gerritsen WR; Jagiello CA; Bourhis JH
Bone Marrow Transplant; 1994 Apr; 13(4):441-7. PubMed ID: 8019469
[TBL] [Abstract][Full Text] [Related]
13. Elevated inflammatory cytokine levels in bone marrow graft rejection.
Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
Transplantation; 1995 Nov; 60(9):943-8. PubMed ID: 7491698
[TBL] [Abstract][Full Text] [Related]
14. Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
Verdonck LF; van Blokland WT; Bosboom-Kalsbeek EK; van Heugten HG; Tilanus MG; de Weger RA
Bone Marrow Transplant; 1996 Aug; 18(2):389-95. PubMed ID: 8864451
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose.
Keever-Taylor CA; Klein JP; Eastwood D; Bredeson C; Margolis DA; Burns WH; Vesole DH
Bone Marrow Transplant; 2001 Apr; 27(8):791-800. PubMed ID: 11477435
[TBL] [Abstract][Full Text] [Related]
18. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
19. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
[TBL] [Abstract][Full Text] [Related]
20. Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence.
van den Berg H; Vossen JM; Langlois van den Bergh R; Bayer J; van Tol MJ
Lab Invest; 1991 May; 64(5):623-8. PubMed ID: 2030576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
